155 related articles for article (PubMed ID: 30359249)
1. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
BMC Cancer; 2018 Oct; 18(1):1039. PubMed ID: 30359249
[TBL] [Abstract][Full Text] [Related]
2. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
Int J Gynecol Cancer; 2019 Mar; 29(3):593-598. PubMed ID: 30821698
[TBL] [Abstract][Full Text] [Related]
3. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
Fong A; Cass I; John C; Gillen J; Moore KM; Gangi A; Walsh C; Li AJ; Rimel BJ; Karlan BY; Amersi F
Am Surg; 2020 Oct; 86(10):1243-1247. PubMed ID: 33106023
[No Abstract] [Full Text] [Related]
5. Predictors of survival trajectories among women with epithelial ovarian cancer.
Peres LC; Sinha S; Townsend MK; Fridley BL; Karlan BY; Lutgendorf SK; Shinn E; Sood AK; Tworoger SS
Gynecol Oncol; 2020 Feb; 156(2):459-466. PubMed ID: 31839342
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.
Hanley GE; Kaur P; Berchuck A; Chase A; Grout B; Deurloo CM; Pike M; Richardson J; Terry KL; Webb PM; Pearce CL
Gynecol Oncol; 2021 Aug; 162(2):461-468. PubMed ID: 34090707
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Artioli G; Giannone G; Valabrega G; Maggiorotto F; Genta S; Pignata S; Lorusso D; Cormio G; Scalone S; Nicoletto MO; Greco F; Rossi E; Spagnoletti I; De Giorgi U; Orditura M; Mosconi AM; Kardhashi A; Bogliolo S; Borgato L
Gynecol Oncol; 2021 Jun; 161(3):755-761. PubMed ID: 33888336
[TBL] [Abstract][Full Text] [Related]
8. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of germline pathogenic
Morgan RD; Burghel GJ; Flaum N; Bulman M; Clamp AR; Hasan J; Mitchell CL; Schlecht H; Woodward ER; Lallo FI; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR
J Med Genet; 2019 May; 56(5):301-307. PubMed ID: 30683677
[TBL] [Abstract][Full Text] [Related]
10. Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
Helpman L; Zidan O; Friedman E; Kalfon S; Perri T; Ben-Baruch G; Korach J
J Gynecol Oncol; 2017 Sep; 28(5):e61. PubMed ID: 28657222
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.
John CS; Fong A; Alban R; Gillen J; Moore KM; Walsh CS; Li AJ; Rimel BJ; Amersi F; Cass I
Gynecol Oncol; 2022 Jan; 164(1):202-207. PubMed ID: 34862065
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
De Nonneville A; Zemmour C; Frank S; Joly F; Ray-Coquard I; Costaz H; Classe JM; Floquet A; De la Motte Rouge T; Colombo PE; Sauterey B; Leblanc E; Pomel C; Marchal F; Barranger E; Savoye AM; Guillemet C; Petit T; Pautier P; Rouzier R; Gladieff L; Simon G; Courtinard C; Sabatier R
Gynecol Oncol; 2021 Oct; 163(1):64-71. PubMed ID: 34294414
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in
Nañez A; Stram DA; Bethan Powell C; Garcia C
Gynecol Oncol Rep; 2022 Feb; 39():100899. PubMed ID: 34917730
[TBL] [Abstract][Full Text] [Related]
14. Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers.
Leung AC; Cook LS; Swenerton K; Gilks B; Gallagher RP; Magliocco A; Steed H; Köbel M; Nation J; Brooks-Wilson A; Le ND
Cancer Epidemiol; 2016 Dec; 45():119-125. PubMed ID: 27810483
[TBL] [Abstract][Full Text] [Related]
15. Long-term mortality among women with epithelial ovarian cancer.
Dinkelspiel HE; Champer M; Hou J; Tergas A; Burke WM; Huang Y; Neugut AI; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2015 Aug; 138(2):421-8. PubMed ID: 26050923
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.
Paik ES; Heo EJ; Choi CH; Kim JH; Kim JW; Kim YM; Park SY; Lee JW; Kim JW; Kim BG
Cancer Sci; 2021 Dec; 112(12):5055-5067. PubMed ID: 34657357
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
[TBL] [Abstract][Full Text] [Related]
19. Period Analysis of Intraracial Differences in Incidence and Survival Rates in Epithelial Ovarian Cancer.
Han L; Husaiyin S; Liu J; Maimaiti M; Niyazi M; Li L
Comput Math Methods Med; 2021; 2021():8032209. PubMed ID: 34925544
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
